HOME Study: Hysteroscopic Office Myomectomy Evaluation

2014-07-24 14:00:52 | BioPortfolio


The purpose of this study is to demonstrate safety and effectiveness of the MyoSure Tissue Removal System when used by community gynecologists in an office setting for the treatment of patients with symptomatic intrauterine polyps and submucosal fibroids.


One hundred subjects will be enrolled in a randomized, comparative setting study conducted at 10-15 investigational sites. Sixty subjects will be randomized to undergo treatment in an office setting, and 40 subjects will be randomized to undergo treatment in a hospital or ambulatory surgical center (ASC) setting. Subjects will undergo a hysteroscopic tissue removal procedure to remove intrauterine polyps, type 0 fibroids, or type I fibroids. Saline infused sonohysterogram images (SIS) obtained at three months post treatment will be compared to pre-treatment images, to determine the percent reduction in target pathology volume. Additionally, subject self-reported pain scores (as rated on an 11 point scale) will compare pain occurring during the treatment procedure to the average pain level experienced during a PAP smear. Economic data will be collected and compared between the two treatment settings.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Uterine Fibroids


Hysteroscopic Morcellator (The MyoSure Tissue Removal Device)


Women's Health Research
United States




Interlace Medical, Inc.

Results (where available)

View Results


Published on BioPortfolio: 2014-07-24T14:00:52-0400

Clinical Trials [1580 Associated Clinical Trials listed on BioPortfolio]

Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System

The purpose of this study is to develop a recommended local anesthetic protocol and post-treatment pain management regimen, in order to assure patient comfort during office-based treatment...

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

This study assesses the effectiveness of intrauterine fibroid and polyp removal using the Interlace Medical 1st generation hysteroscopic morcellator device based on a retrospective review ...

Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata

The purpose of the current study is to evaluate the technical success, safety and procedure feasibility of hysteroscopic cryoablation treatment of symptomatic uterine fibroids in women who...

MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation

The goal of this study is to validate the new ExAblate Application software V4.2 by developing additional data that shows the safety of this treatment. The ExAblate is intended to ablate u...

Radiofrequency Ablation of Uterine Fibroids

This research study is being conducted to evaluate the safety and effectiveness of ablation (destruction) of uterine leiomyomas (fibroids) using electrocautery heating guided by ultrasound...

PubMed Articles [11237 Associated PubMed Articles listed on BioPortfolio]

Hysteroscopic Myomectomy of a Large Submucosal Leiomyoma with Novel Use of Fluid Warming.

Uterine fibroid size is often considered a limiting factor for considering the surgical approach to myomectomy. In this case, a 35-year-old woman presented with heavy menstrual bleeding and desire for...

Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.

Ulipristal acetate (UPA) is a selective progesterone receptor modulator, which has been used to treat uterine fibroids. Many published reports about the outcomes indicate effective control of bleeding...

Misdiagnosis of leiomyosarcoma after radiofrequency ablation of uterine fibroids.

Minimally invasive therapies to treat symptoms of uterine fibroids can be effective alternatives to major surgery. Such modalities include pharmacologic agents, uterine artery embolization (UAE), MR g...

Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of US Women.

Most women will experience uterine fibroids by the age of 50, yet few data exist describing the overall patient experience with fibroids. The objective of this population-based survey was to character...

Women with Newly Diagnosed Uterine Fibroids: Treatment Patterns and Cost Comparison for Select Treatment Options.

The primary objective of this study was to describe surgical treatment patterns among women with newly diagnosed uterine fibroids (UF). A secondary objective was to estimate the medical costs associat...

Medical and Biotech [MESH] Definitions

Removal of an implanted therapeutic or prosthetic device.

Removal of a MEDICAL DEVICE from the market due to the identification of an intrinsic property of the device that results in a serious risk to public health.

Removal of a MEDICAL DEVICE from the market due to a problem occurring in the manufacture or distribution of the product.

Surgical removal of a LEIOMYOMA of the UTERUS.

Contraceptive devices placed high in the uterine fundus with a string extending from the device through the cervical as into the vagina. (UMDNS, 1999)

More From BioPortfolio on "HOME Study: Hysteroscopic Office Myomectomy Evaluation"

Quick Search


Relevant Topic

Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Searches Linking to this Trial